%0 Journal Article
%T Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States
%A Alexander Liede
%A Diane Reams
%A Elizabeth O¡¯Donnell
%A Leah J. McGrath
%A M. Alan Brookhart
%A Robert Overman
%A Rohini K. Hernandez
%J Archive of "Cancer Medicine".
%D 2019
%R 10.1002/cam4.1869
%X Prior to 2018, intravenous bisphosphonates (IV BPs) were the only therapies recommended to prevent skeletal©\related events for patients diagnosed with multiple myeloma (MM). We examined patterns of IV BP initiation and interruption among patients with newly diagnosed MM (NDMM) in the United States
%K bisphosphonates
%K electronic health records
%K medical record linkage
%K multiple myeloma
%K zoledronic acid
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346250/